Session Descriptions

What Sessions Are Right For You?

Business discipline icons and education levels (All Levels, Intermediate and Advanced) are listed by each session to help you determine which business, policy and technology sessions are right for you.

Education Sessions Key
E-Business, MIS/IT, E-Commerce, Technical Track & Trace, Pedigree, RFID
Financial, Purchasing, Contract Administration Trade/Industry Relations, Sales and Marketing
Government, Regulatory Supply Chain, Operations, Logistics, Distribution

Level of Education

The level of education provided also is identified in the complete session descriptions. The levels are All Levels Welcome; Intermediate and Advanced.

Click on the following to see the business program for each day of the conference.
Monday, March 15
Tuesday, March 16
Wednesday, March 17

MONDAY, MARCH 15
Opening General Session | 8:30 AM–9:45 AM

Welcome
John M. Gray, President and CEO, HDMA

HDMA President and CEO John M. Gray will open the 2010 Distribution Management Conference & Technology Expo and apprise attendees of the latest updates on HDMA’s priorities across the industry, in statehouses and on Capitol Hill.

You will hear about how health reform initiatives will affect the distribution industry, the latest solutions to such industry challenges as in-transit security and the response of the supply chain to such public health crises as the H1N1 influenza pandemic. As the distribution industry evolves, best practices become the industry standard, and new innovations and technologies emerge to meet the needs of the healthcare system. Gray will provide his unique insight into how distributors thrive by staying ahead of the ever-changing conditions of the pharmaceutical marketplace.

Keynote Presentation: Solving the Healthcare Crisis
Senator Tom Daschle, Former Senate Majority and Minority Leader

One of the most influential men in Washington today, Tom Daschle is a former senator whose lifelong passion and commitment to public service and healthcare reform is undeniable. As Senate majority and minority leader from 1994 to 2005, he cultivated a legacy as a dynamic party leader and tireless fighter for the common man. Senator Daschle remains committed to everyday Americans. He is an outspoken advocate for healthcare reform and a well-connected voice among the healthcare industry and Washington policy makers.

Based on his book, Critical: What We Can Do About the Health-Care Crisis, Senator Daschle outlines the healthcare reform strategies that form the foundation of President Obama’s healthcare plan. Evaluating where previous attempts at national healthcare coverage have succeeded and where they have gone wrong, he explains the complex social, economic and medical issues involved in reform and sets forth his vision for change.

Concurrent Business, Policy and Technology Sessions

Trade/Industry Relations, Sales and Marketing Government, Regulatory

Reimbursement Update
10:00 AM-11:00 AM | Level: Advanced

Larri A. Short, Esq., Partner, Health Law Group, Arent Fox, LLP

As federal and local governments struggle with tight budgets, there will be increasing pressure to control healthcare costs — especially through reductions in reimbursement for pharmaceuticals. Hear a comprehensive overview and update of current federal reimbursement policies under the Medicare, Medicaid and 340B drug programs in this session. Learn about legislative, judicial, and regulatory initiatives affecting Average Wholesale Price (AWP), Average Manufacturer Price (AMP), Average Sales Price (ASP) and Wholesale Acquisition Cost (WAC) and better understand how these initiatives will impact your bottom line. 

Financial, Purchasing, Contract Administration E-Business, MIS/IT, E-Commerce, Technical Trade/Industry Relations, Sales and Marketing Supply Chain, Operations, Logistics, Distribution

Predictive Analytics
10:00 AM-11:00 AM | Level: Intermediate

John Boyne, Senior Managing Director, J3LM LLC

When firms address value chains in their entirety, rather than just parts of the whole, everyone in the value chain benefits. Supply chain orchestrators must push intelligence to the edge of their value chains, ensuring that every trading partner can have the same level of sophistication and resilience as the orchestrator. Learn how companies can use predictive analytics capabilities to achieve near-real-time collaborative planning, forecasting and replenishment.

Financial, Purchasing, Contract Administration Trade/Industry Relations, Sales and Marketing Supply Chain, Operations, Logistics, Distribution Government, Regulatory

Managing Returned Goods: Connecting Forward and Reverse Logistics
10:00 AM-11:00 AM | Level: Intermediate
Sponsored by Guaranteed Returns

Thomas Bloemeke, Manager, Returns, Recalls and Unsaleables, GlaxoSmithKline
Thomas Hervey, Logistics Operations Coordinator Pharmacy, Wal-Mart Stores, Inc.
Michael Kody, Vice President, Supply Chain Solutions, AmerisourceBergen Drug Company

Discuss how policies and practices in the supply chain impact the volume of expired returned goods in the channel. Address product lifecycle issues — including manufacturer and distributor ship-life policies and warehouse and pharmacy stock rotation practices — as they affect returns of unsaleable product.

Concurrent Business, Policy and Technology Sessions

Trade/Industry Relations, Sales and Marketing Government, Regulatory Supply Chain, Operations, Logistics, Distribution

DEA Update
11:15 AM-12:15 PM | Level: Intermediate

Mark Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration (DEA)

Discuss and explore perspectives about recent and upcoming Drug Enforcement Administration (DEA) initiatives, including implementation of the Ryan Haight Online Pharmacy Act Interim Final Rule, inspections and controlled substances monitoring and reporting.
Note: This session is closed to the media.

Financial, Purchasing, Contract Administration Trade/Industry Relations, Sales and Marketing Supply Chain, Operations, Logistics, Distribution Government, Regulatory

Linking the Supply Chain:
Connecting Manufacturing and Distribution
11:15 AM-12:15 PM | Level: Intermediate

Steve Tadevich, Director, Account Management, McKesson Corporation
Heather Zenk, PharmD, Director, Integrated Solutions, AmerisourceBergen Drug Company

Trends in distribution processes and automation in areas such as returns, cold chain handling, automated picking or even “green” initiatives could affect how manufacturers bring products to market. Learn ways to help link manufacturing, packaging and product teams to the distribution channel for the benefit of all.

Financial, Purchasing, Contract Administration E-Business, MIS/IT, E-Commerce, Technical Trade/Industry Relations, Sales and Marketing Supply Chain, Operations, Logistics, Distribution

The Impact of Mergers and Acquisitions
11:15 AM-12:15 PM | Level: Advanced

Linda Ewald, Vice President, Contracts and Chargebacks, AmerisourceBergen Drug Company
Rich Fleshman, Manager, Contracts and Pricing, Cardinal Health, Inc.

The industry has seen continuous product line acquisition and merger activity in recent months and years. Join professionals from the contracting and supply chain side of the industry for a practical discussion on the impact of acquisition and merger activity on the contract administration process, and ultimately the entire healthcare supply chain.

Concurrent Business, Policy and Technology Sessions

Track & Trace, Pedigree, RFID Financial, Purchasing, Contract Administration Trade/Industry Relations, Sales and Marketing Supply Chain, Operations, Logistics, Distribution Government, Regulatory

Regulating Reverse Logistics
2:15 PM-3:15 PM | Level: Intermediate

Lisa M. Lauer, Environmental Protection Specialist, Office of Resource Conservation and Recovery, U.S. Environmental Protection Agency

Learn the latest about federal and state expectations for reverse logistics and their impact on operations. Examine the status of pending regulations and guidance, including the impact of DEA and EPA proposals on waste management and returns processes.

Supply Chain, Operations, Logistics, Distribution Government, Regulatory

In-Transit Security: Part I
2:15 PM-3:15 PM | Level: Advanced
Sponsored by CargoNet

Charles Forsaith, Corporate Director, Supply Chain Security, Purdue Pharma L.P.
Jay Spellman, Director, Logistics, Anda, Inc.

Learn about the newest strategies and tactics used to ensure in-transit security. This session explores the current security issues faced by the healthcare supply chain, reviews best practices and the latest technologies.
Note: This session is closed to the media.

Financial, Purchasing, Contract Administration Supply Chain, Operations, Logistics, Distribution

Facts and Figures in Traditional and Specialty Distribution
2:15 PM-3:15 PM | Level: All Levels

Rolando DeCardenas, Vice President, General Manager, Oncology Rx Biopharmaceutical Solutions Group, US Oncology
Joseph P. Perri, CPA, Regional Director Finance, East Region, AmerisourceBergen Drug Company

Get a broader picture of the healthcare supply chain facts, figures and trends from the Center for Healthcare Supply Chain Research, HDMA’s research foundation. Analyze groundbreaking industry benchmarks reported in the first edition of Specialty Pharmaceuticals: Facts Figures and Trends. Learn about the enhancements and updates to the 2009-2010 HDMA Factbook.

Concurrent Business, Policy and Technology Sessions

Track & Trace, Pedigree, RFID Supply Chain, Operations, Logistics, Distribution Government, Regulatory

State Pedigree and Licensure Issues
3:30 PM-4:30 PM | Level: Intermediate

Daniel G. Bellingham, Director, State Government Affairs, HDMA
Joshua M. Bolin, Field Services Senior Manager, National Association of Boards of Pharmacy

Examine the latest changes in state distributor and manufacturer licensure requirements. Pedigree, in-transit issues and VAWD (accreditation) are just a few of the topics that will be addressed.

Supply Chain, Operations, Logistics, Distribution Government, Regulatory

In-Transit Security: Part II
3:30 AM-4:30 PM | Level: Advanced
Sponsored by CargoNet

Charles Forsaith, Corporate Director, Supply Chain Security, Purdue Pharma L.P.
Jay Spellman, Director, Logistics, Anda, Inc.

This session continues discussions from the first in-transit security session. Review best practices and the latest technologies to ensure in-transit security and preview HDMA’s in-transit security guidelines. 
Note: This session is closed to the media.

Track & Trace, Pedigree, RFID Trade/Industry Relations, Sales and Marketing Supply Chain, Operations, Logistics, Distribution Government, Regulatory

Current Trends in the Healthcare Value Chain:
Data Sharing and Collaboration
3:30 PM-4:30 PM | Level: Intermediate

Hussain Mooraj, Vice President and Head of Healthcare Research, Gartner, Inc.

Examine the role of data sharing in the healthcare value chain. To what degree do organizations in the healthcare value chain realize the potential of demand information and the opportunities to leverage that data for better patient, regulatory and financial outcomes? What are the benefits of visibility in the healthcare value chain?

TUESDAY, MARCH 16
Morning General Session | 8:30 AM–9:45 AM

HDMA Distribution Management Award Presentation

Join HDMA to celebrate supply chain excellence with the presentation of the new Distribution Management Award, the successor to the Innovation for Success and iBusiness Solution awards. The award honors member companies’ efforts to improve the efficiency and effectiveness of the healthcare supply chain and enhance trading partner relationships.

Recognized distributors, manufacturers or service providers demonstrate the value of distribution by developing creative and results-oriented initiatives in areas ranging from technology and operations best practices to trade and promotional planning that benefit the supply chain, customers and healthcare consumers.

Competitive Leadership: Twelve Principles for Success
Brian Billick, FOX NFL Analyst, NFL Network Contributor, and Former Super Bowl-Winning Head Coach, Baltimore Ravens

Can successful leadership be learned? Legendary professional football coach Brian Billick thinks so. He knows that leadership isn’t some abstract concept, but something that can be learned and understood.

In this presentation, based on his book of the same name, Billick shares key principles of effective leadership that can be applied to any competitive situation, showing audiences how to overcome adversity and succeed. In a powerful and engaging presentation, he discusses the value of creative thinking, how to create your own opportunities and how to inspire confidence in yourself and others.

From 1999-2007, Billick served as the head coach of the Baltimore Ravens, a new franchise with some of the youngest players in NFL history. In his first year as head coach, Billick guided the Ravens to their first non-losing season (8-8). In 2000, he led the Ravens to a decisive 34-7 Super Bowl XXXV victory over the New York Giants. Currently an analyst for FOX TV Sports and a contributor to the NFL Network, Billick shares his methods for bringing teams together to focus on achieving common goals.

Concurrent Business, Policy and Technology Sessions

Trade/Industry Relations, Sales and Marketing Financial, Purchasing, Contract Administration Supply Chain, Operations, Logistics, Distribution E-Business, MIS/IT, E-Commerce, Technical

Lean Six Sigma
10:00 AM-11:00 AM | Level: Intermediate

Ronald Vaske, Senior Director, Business Process, McKesson Corporation

Studies of leading Six Sigma and Lean Six Sigma organizations indicate that such practices can lead to savings percent of up to to 4.5 percent of revenue. Learn how to achieve better business results by leveraging existing systems, business processes and workflow, while balancing implementation and operation costs.

These two-hour sessions allow for a comprehensive exploration of critical industry topics.

Trade/Industry Relations, Sales and Marketing Government, Regulatory Supply Chain, Operations, Logistics, Distribution

Update on FDA’s Risk Evaluation & Mitigation Strategies (REMS)
10:00 AM-12:00 PM | Level: Advanced

Kathleen R. Frost, Associate Director for Regulatory Policy, Office of Surveillance and Epidemiology, CDER, U.S. Food and Drug Administration (FDA)
J. David Haddox, DDS, MD, Vice President, Health Policy, Purdue Pharma L.P.
Kevin N. Nicholson, RPh, JD, Vice President, Government Affairs and Public Policy, National Association of Chain Drug Stores
Bradley T. Pine, Compliance Director, Regulatory and Supply, Smith Drug Company, Div. J M Smith Corporation
Will Rowe, Chief Executive Officer, American Pain Foundation

Explore and better understand the recent developments surrounding the implementation of FDA’s Risk Evaluation and Mitigation Strategies (REMS). This session builds on last year’s discussion and updates manufacturers and distributors on the FDA’s REMS decisions. Find out more about implementation issues and discuss business implications, including standards and consistency in the healthcare marketplace.

Trade/Industry Relations, Sales and Marketing Financial, Purchasing, Contract Administration Supply Chain, Operations, Logistics, Distribution E-Business, MIS/IT, E-Commerce, Technical

Data-Driven Success
10:00 AM-12:00 PM | Level: Advanced

Randy J. Bradway, MS, RPh, Vice President, Commercial Operations, Cephalon Inc.
David W. Janca, Founder and CEO, ValueCentric, LLC
Diane McLean, Vice President, Accounts Payable, McKesson Corporation

The growing exchange of data to fulfill agreements and provide transparency in the healthcare supply chain raises important questions. What is the best way to use data to increase efficiency, reduce cost and enhance trading partner relationships? Explore opportunities to leverage shared data and achieve new levels of success.

Concurrent Business, Policy and Technology Sessions

Trade/Industry Relations, Sales and Marketing Track & Trace, Pedigree, RFID Supply Chain, Operations, Logistics, Distribution E-Business, MIS/IT, E-Commerce, Technical

Pharmaceutical Distribution 2015: A Technology Roadmap
1:45 PM-2:45 PM | Level: Advanced

Steven Lefebure, Research Vice President, Industry Advisory Services – Life Sciences / Consumer, Gartner, Inc.

Learn about key trends driving change and innovation in pharmaceutical distribution and gain insight into the technologies that are needed to make that vision a reality for your company. Learn about trend topics, such as revenue management, contract management, supply chain, track-and-trace, serialization, REMS and e-Prescribing. Find out how the industry can create next generation processes and how to proactively plan for changes; industry predictions that will propel change and innovation in the supply chain will be explored.

Trade/Industry Relations, Sales and Marketing Government, Regulatory Supply Chain, Operations, Logistics, Distribution

Pandemic Planning and Emergency Preparedness
1:45 PM-2:45 PM | Level: All Levels

Stephen C. Curren, Deputy Program Manager, Critical Infrastructure Protection Program, U.S. Department of Health and Human Services

Communication and coordination among supply chain partners is necessary in order to deliver critical medicines and supplies, especially during such severe emergencies as a pandemic outbreak. The H1N1 influenza pandemic highlighted success in public-private cooperation — and identified several areas of focus for the future. Hear an overview of the Department of Homeland Security’s Critical Infrastructure Protection Program and explore the available tools for the private sector to enhance communications before and during an emergency. This session will focus on the federal government’s attention to threats facing the public health sector and highlight how healthcare production and distribution facilities fit into the network of critical infrastructure.

Trade/Industry Relations, Sales and Marketing Government, Regulatory Supply Chain, Operations, Logistics, Distribution E-Business, MIS/IT, E-Commerce, Technical

Consumer Product Safety Improvement Act
1:45 PM-2:45 PM | Level: All Levels

Cheryl A. Falvey, Esq., General Counsel, Consumer Product Safety Commission
Kristin Muhlner, Chief Executive Officer, RollStream, Inc.

The Consumer Product Safety Improvement Act (CPSIA) requires importers and U.S. manufacturers to provide General Conformity Certificates (GCCs) to distributors or retailers when they sell “covered” products. This session will discuss the CPSIA’s requirements for both manufacturers and distributors, including providing GCCs. Impacts on the supply chain, factors to consider when setting up compliance mechanisms and potential solutions for pharmaceutical manufacturers, distributors, repackagers and their customers will be highlighted.

Afternoon General Session | 3:00 PM-4:00 PM

What’s In, What’s Out, What’s Ahead: 2010 Healthcare Marketplace Trends
Doug Long, Vice President, Industry Relations, IMS Health
Sponsored by SAP America, Inc.

Take a first look at the latest industry data and emerging market trends for branded and generic pharmaceutical and health and beauty care product sales, presented by Doug Long of IMS Health. Long is an industry thought leader who specializes in analyzing information from IMS Health’s sales, prescription, promotional and medical databases.

Long offers perspectives on a range of vital pharmaceutical topics, including global market trends, industry forecasts, research and development, marketing practices, blockbuster drugs, patent expirations and generic trends, biotechnology and more. Take advantage of this opportunity to learn how emerging trends will affect strategic business plans in the coming year and beyond.

Long has considerable experience with the changing U.S. and global healthcare marketplaces, as well as insight into healthcare distribution. He develops information for data partners, and manages supplier, manufacturer and association relationships. Prior to IMS Health, Long worked at Nielsen Market Research for 16 years in various sales and marketing capacities. Long received a BA from DePauw University and an MBA in Management from Fairleigh Dickinson University.

WEDNESDAY, MARCH 17
Morning General Session | 8:30 AM–9:30 AM

A 21st Century FDA
Andrew C. von Eschenbach, MD, Senior Director of Strategic Initiatives,
Center for Health Transformation, Former Commissioner, U.S. Food and Drug Administration (FDA)

Andrew C. von Eschenbach, MD is Senior Director for Strategic Initiatives at the Center for Health Transformation (CHT) and former FDA Commissioner and Director of the National Cancer Institute. During his tenure at the FDA, Dr. von Eschenbach set out to modernize the Agency, helping to design a variety of new programs to strengthen the FDA in its mission to protect and promote public health. Dr. von Eschenbach has held numerous leadership roles throughout his career, entering government service with an outstanding career over three decades as a renowned physician, surgeon, oncologist and medical executive, including Executive Vice President at the University of Texas MD Anderson Cancer Center. 

Dr. von Eschenbach will discuss the FDA Modernization Project recently launched by the CHT, including steps to ensure the integrity of the food, drugs and medical devices that move through the supply chain. He will highlight the FDA’s Risk Evaluation and Mitigation Strategies program and its implications for supply chain participants, as well as other agency strategies aimed to ensure the safety of medications, including the FDA’s sentinel initiative.

Closing General Session | 9:45 AM–11:00 AM

A View from the Customer: Panel Discussion
Panel Moderator: Doug Long, Vice President, Industry Relations, IMS Health

John Fegan, Vice President, Winn-Dixie
Heather Paton, Senior Director, Pharmacy Contract Management, Novation, LLC
Ralph Petri, Executive Vice President, Pharmacy and Supply Chain Operations, Kerr Drug
Ernie Richardsen, Group Vice President, Pharmaceutical Purchasing and Clinical Services, Rite Aid Corporation

The healthcare supply chain exists to safely and efficiently serve more than 165,000 pharmacy settings across the United States. Distributors and manufacturers work together every day to reduce costs and enhance services. But it is the needs of various customers — and ultimately patients — that drive business. Examine customer expectations, needs and challenges and explore customer opinions of working with the healthcare supply chain in a panel discussion moderated by Doug Long of IMS Health.